Slide background

Slide background
Slide background
Slide background

Loading Events
JLABS @ NYC: Lessons in Herding Cats

11:00 AM — 1:00 PM

Business Development for Life Science Companies

See New York Genome Center’s lecture series, events and archives VIEW FULL CALENDAR



Lessons in Herding Cats: Business Development for Life Science Companies



In this workshop, attendees will hear from a deal making team at Johnson & Johnson Innovation and learn fundamental business development skills to help successfully evaluate and manage strategic alliances and other potential growth opportunities. 


Topics will include:

    *Strategic alliance process management

    *Concepts in valuation

    *Technical diligence

    *Communication and negotiation skills


This workshop is geared towards business development professionals and management teams of life science startups. 





11:00 AM | Registration Opens, Networking & Lunch
11:30 AM | Presentations
12:30 PM | Q&A
1:30 PM | Program Close





$35 | General Public
$20| Student/Academic
$45 | At the Door








New York Genome Center
101 Avenue of the Americas,
1st Floor, Auditorium
New York, NY 10013





Jill McManus | Finance Director, Johnson & Johnson Innovation


In Ms. McManus’ current role, she is the Finance Director for the Boston J&J Innovation Center focusing on early stage deal structures with external partners. Prior to this role, she supported the DePuy Synthes organization where started as a Senior Financial Analyst in Recon Supply Chain where she worked on the divestiture of the New Bedford instrument facility.


To learn more about Ms. McManus, visit her bio.



Jim Tobin, PhD | Vice President of Cardiovascular & Metabolic Scientific Innovation, Johnson & Johnson Innovation


Jim Tobin, PhD, has over 19 years of drug development experience in the areas of hemostasis, inflammation, muscle degenerative diseases and diabetes. Most recently, Dr. Tobin was an entrepreneur-in-residence at Atlas Venture and focused on company formation in the life science sector.


To learn more about Dr. Tobin, visit his bio.



Erin Washington | Senior Manager, Transactions & Business Analytics, Johnson & Johnson Innovation


Ms. Erin Washington is responsible for developing and executing transactions with Johnson & Johnson Innovation’s diverse industry partners, including biotech companies, venture capital funds, non-profit organizations, governments, and academic institutions to access innovation across J&J’s areas of interest – Pharmaceutical Therapeutic Areas, Consumer Need States, and Medical Device Businesses.


To learn more about Ms. Washington, visit her bio.


  • +
    Five Points lecture series bring leading scientists from around the world for an in-depth discussion of their work with students, researchers and clinicians from the New York Genome Center, its member institutions, and others in the medical/scientific community. While Five Points lectures are free and open to the general public, these lectures are most beneficial to scientists, clinicians and researchers who wish to accelerate their research through the use of DNA sequencing technology and bioinformatics. Five Points lectures often frame five or so key points, in a nod to the series’ name — followed by 15 minutes of Q&A, and 30 minutes of networking over hors d’oeuvres and cocktails. These afternoon events are held in the Center’s state-of-the-art ground-floor auditorium starting at 4 pm.

  • +